glp-1 source Glucagon-like peptide 1 (GLP-1) A Tale of Two Incretins

GLP-1 Agonists Are Linked to Serious Complications Recent reports and litigation involving GLP-1 agonists have focused on serious vision-related injuries, including non-arteritic anterior ischemic optic neuropathy (NAION), sometimes referred to in the media as Ozempic blindness. NAION is a condition caused by reduced blood flow to the optic nerve and may lead to sudden, permanent vision loss

Who is it for: Wegovy is recommended for pre-, peri- and post-menopausal women who qualify for weight loss treatments and would benefit from a holistic platform with 24/7 access to physicians and a supportive community of experts and other women in this life stage

The first GLP-1 drug, Exenatide (brand name Byetta), was approved by the Food and Drug Administration in 2005 to treat type 2 diabetes

Riesgos de Pancreatitis y Cncer Aunque inicialmente hubo preocupaciones sobre una posible asociacin entre el uso de GLP-1RA y el desarrollo de pancreatitis o cncer pancretico, estudios clnicos y datos del mundo real no han confirmado estos riesgos

The company partners with licensed pharmacies and provides ongoing clinical support designed to help patients navigate treatment responsibly